GVHD
We measured the concentrations of 4 GVHD biomarkers (ST2, REG3a, TNFR1, and IL-2Ra) and used them to model 6-month NRM using rigorous cross-validation strategies to identify the best algorithm that defined 2 distinct risk groups.